Literature DB >> 12161153

Arylpiperazine substituted heterocycles as selective alpha(1a) adrenergic antagonists.

Haripada Khatuya1, Richard H Hutchings, Gee-Hong Kuo, Virginia L Pulito, Linda K Jolliffe, Xiaobing Li, William V Murray.   

Abstract

Antagonists of the alpha(1)-adrenergic receptors (alpha(1)-ARs) are useful for the treatment of benign prostatic hyperplasia. A series of potent and subtype-selective alpha(1a)-AR antagonists has been synthesized, displaying in vitro binding affinity in the low the nanomolar range.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12161153     DOI: 10.1016/s0960-894x(02)00436-5

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  2 in total

1.  Synthesis and Evaluation of the First Fluorescent Antagonists of the Human P2Y2 Receptor Based on AR-C118925.

Authors:  Sean Conroy; Nicholas D Kindon; Jacqueline Glenn; Leigh A Stoddart; Richard J Lewis; Stephen J Hill; Barrie Kellam; Michael J Stocks
Journal:  J Med Chem       Date:  2018-03-28       Impact factor: 7.446

2.  Synthesis and cytotoxic activity evaluation of novel arylpiperazine derivatives on human prostate cancer cell lines.

Authors:  Hong Chen; Xue Liang; Fang Xu; Bingbing Xu; Xuelan He; Biyun Huang; Mu Yuan
Journal:  Molecules       Date:  2014-08-12       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.